- Home
- BDN vs QURE Comparison
BDN vs QURE Comparison
Compare BDN & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDN
- QURE
- Stock Information
- Founded
- BDN 1986
- QURE 1998
- Country
- BDN United States
- QURE Netherlands
- Employees
- BDN N/A
- QURE N/A
- Industry
- BDN Real Estate Investment Trusts
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- BDN Real Estate
- QURE Health Care
- Exchange
- BDN Nasdaq
- QURE Nasdaq
- Market Cap
- BDN 721.2M
- QURE 725.4M
- IPO Year
- BDN N/A
- QURE 2007
- Fundamental
- Price
- BDN $4.47
- QURE $17.27
- Analyst Decision
- BDN Hold
- QURE Strong Buy
- Analyst Count
- BDN 1
- QURE 10
- Target Price
- BDN $5.00
- QURE $37.20
- AVG Volume (30 Days)
- BDN 1.8M
- QURE 1.4M
- Earning Date
- BDN 07-23-2025
- QURE 07-31-2025
- Dividend Yield
- BDN 13.45%
- QURE N/A
- EPS Growth
- BDN N/A
- QURE N/A
- EPS
- BDN N/A
- QURE N/A
- Revenue
- BDN $312,538,000.00
- QURE $20,201,000.00
- Revenue This Year
- BDN $58.09
- QURE $27.16
- Revenue Next Year
- BDN $4.92
- QURE $248.21
- P/E Ratio
- BDN N/A
- QURE N/A
- Revenue Growth
- BDN N/A
- QURE 6.30
- 52 Week Low
- BDN $3.41
- QURE $3.73
- 52 Week High
- BDN $6.54
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- BDN 64.93
- QURE 67.53
- Support Level
- BDN $4.13
- QURE $14.75
- Resistance Level
- BDN $4.26
- QURE $15.50
- Average True Range (ATR)
- BDN 0.10
- QURE 1.07
- MACD
- BDN 0.02
- QURE 0.16
- Stochastic Oscillator
- BDN 94.34
- QURE 93.40
About BDN Brandywine Realty Trust
Brandywine Realty Trust engaged in the acquisition, development, redevelopment, ownership, management, and operation of a portfolio of office, life science/lab, residential, and mixed-use properties. The company owned and managed properties within five segments. The Philadelphia CBD segment includes properties located in the City of Philadelphia in Pennsylvania. The Pennsylvania Suburbs segment includes properties in Chester, Delaware and Montgomery counties in the Philadelphia suburbs. The Austin, Texas segment includes properties in the City of Austin, Texas. The Metropolitan Washington, D.C. segment includes properties in Northern Virginia, Washington, D.C. and Southern Maryland. The Other segment includes properties in Camden County, New Jersey and New Castle County, Delaware.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.